Wordt geladen...
Tofacitinib in Rheumatoid Arthritis: Lack of Early Change in Disease Activity and the Probability of Achieving Low Disease Activity at Month 6
OBJECTIVE: Optimal targeted treatment in rheumatoid arthritis requires early identification of failure to respond. This post hoc analysis explored the relationship between early disease activity changes and the achievement of low disease activity (LDA) and remission targets with tofacitinib. METHODS...
Bewaard in:
| Gepubliceerd in: | Arthritis Care Res (Hoboken) |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6590136/ https://ncbi.nlm.nih.gov/pubmed/29696833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.23585 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|